Krystal Biotech Inc (KRYS)

EBITDA Growth

40.00%

Quarterly · Period ending:

KRYS logo

KRYS EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported40.00%
KRYS Quarterly EBITDA YoY % (-548.45% → 40.00%)
High-resolution chart · PNG

KRYS ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
39.9996%
39.6564%
-21.0485%
35.9662%
109.2866%
509.1717%
312.4055%
-55.5948%
172.7562%
121.207%
139.2856%
384.3706%
-16.9542%
28.474%
-47.2886%
-95.0223%
-72.8483%
-255.1219%
-111.7019%
-62.1154%
-146.7694%
-179.651%
-68.1911%
-77.3054%
-11.3036%
-8.0447%
-37.3662%
-73.3176%
-133.3606%
-100.3513%
-185.0133%
-42.3372%
-243.9607%
-390.7328%
-143.6187%
-548.4472%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.